Mar 07, 2023 / 12:00AM GMT
Operator
Thank you for standing by. Welcome to the Merck & Co. Investor Event at ACC.23/WCC. (Operator Instructions) This call is being recorded. If you have any objections, please disconnect at this time.
I would like to turn the meeting over to Mr. Peter Dannenbaum, Vice President, Investor Relations. Sir, you may begin.
Peter Dannenbaum - Merck & Co., Inc. - VP of IR
Thank you very much. Good evening, everyone. Welcome to Merck's Investor Event here at the American College of Cardiology in conjunction with the World Congress of Cardiology. Thank you to all of you in the room here who have made the effort to be with us here in New Orleans, and thanks to everyone that's listening in on the webcast. We're very excited to have this opportunity to speak to you about the significant data that we presented today. During today's call, a slide presentation will accompany our speakers' prepared remarks, and that presentation has been posted to our website.
Before we get started, we would like to remind you that some of the statements that we make
Merck & Co Inc Investor Event at ACC.23/WCC Transcript
Jan 23, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers